UBS Group AG - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 25 filers reported holding ATYR PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$6,950
+231.0%
4,399
+339.9%
0.00%
Q1 2023$2,100
-88.3%
1,000
-83.3%
0.00%
Q3 2022$18,000
+200.0%
5,975
+198.8%
0.00%
Q2 2022$6,000
-71.4%
2,000
-50.0%
0.00%
Q1 2022$21,000
+162.5%
4,000
+253.4%
0.00%
Q4 2021$8,000
-46.7%
1,132
-64.2%
0.00%
Q2 2021$15,000
+200.0%
3,164
+93.3%
0.00%
Q3 2020$5,000
-97.2%
1,637
-95.9%
0.00%
Q2 2020$178,000
+67.9%
40,049
+5.4%
0.00%
Q1 2020$106,000
+657.1%
37,999
+1002.1%
0.00%
Q4 2019$14,0003,4480.00%
Other shareholders
ATYR PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,626,624$7,310,0662.43%
Tikvah Management LLC 2,460,833$3,888,1161.40%
TANG CAPITAL MANAGEMENT LLC 471,134$744,3920.10%
FEDERATED HERMES, INC. 10,169,600$16,067,9680.04%
Alyeska Investment Group, L.P. 2,455,555$3,879,7770.03%
XTX Topco Ltd 73,894$116,7530.02%
ALTERNA WEALTH MANAGEMENT, INC 10,000$15,8000.02%
Pale Fire Capital SE 55,857$88,2540.01%
GSA CAPITAL PARTNERS LLP 27,559$440.00%
Virtu Financial LLC 13,662$220.00%
View complete list of ATYR PHARMA INC shareholders